Cancer Rebel. This was me 3 years ago. My hair grew back WHITE!

Chemo hair growth during taxol

My hair started to grow back during taxol. It was WHITE!

3 years ago today I was in cancer rebel mode.

This time three years ago, my hair was starting to grow back. The first centimetre was snow white. It’s quite a common chemo thing, apparently. The first post chemo hair can be translucent. Absolutely no pigment. It was strange, but I was so happy to take a step towards some kind of normality.

At this point in my treatment, I was on taxol. A weekly chemo, which I found a million times easier than FEC. To start with, it felt like a holiday. The first 24 hours, I would feel woozy and spaced out. Sleepy and a bit dizzy. But no nausea with this one. THANK F! And most of the time I felt fine.

But three quarters of the way through the 3 month treatment plan, my body rebelled. My white blood cell count started to drop and I limped towards the finish line, completely exhausted.

Taxol can cause peripheral neuropathy (nerve damage, usually to hands and feet). I did my best to dodge it with frozen mitts and socks during each treatment. I think I got away with it, although I do wonder if my ongoing foot issues are a delayed response … who knows!

At this point 2 years ago, my oncologist told me to take it easy. It’s one of the only times I didn’t listen to medical advice. I was so over it all. I just wanted to feel normal. To stop being a cancer patient.

So I got on my bike and pedaled.

Up big hills.

Slowly.

But I so needed it.

I needed to feel like me!

Sometimes heart rules over head.

Cancer rebel.

Ps I don’t recommend ignoring your doctor or you body :)

My last few taxol chemo infusions

I was tired by the last few taxol treatments. My white blood cell count tanked.

exercise during cancer treatment made me feel normal

Exercise during cancer treatment made me feel normal

Previous
Previous

Exercise and cancer related foot pain and tendonitis

Next
Next

Exercise can cure the most common cancer side effect, affecting up to 90% of patients.